Manufactured by the Florida-based PharmaTech, the liquid drug or dietary supplement products were distributed by Leader Brand, Major Pharmaceuticals and Rugby Laboratories. The distributors have all issued voluntary
The company has laid off 60 employees under the planned strategic actions, as well as pursuing strategic options for its research and development (R&D) assets. The reduction in
Under the terms of the transaction, the parties will enter into a long-term supply agreement for Perrigo API to supply its inventory of existing commercial and pipeline APIs
Under the revised terms, the option to acquire Sutro has been ceased along with limitations from Sutro entering into additional collaborations or accessing the public financial markets. The
Dubbed DEL MAR stage 2, the phase 2b stage 2 clinical trial assessed the performance of Luminate as either a sequential therapy or in combination with anti-VEGF in 80
Tb535H, which is an anti-5T4 pan-cancer T-cell engager, will get support from the Cancer Research UK in its early clinical development. The first-in-class Fdrug is evolved from Biotecnol’s
Lebrikizumab is a novel and humanized monoclonal antibody designed to specifically block the action of IL-13, a cytokine that is a central pathogenic mediator in atopic dermatitis. Roche
The trial dubbed as STAR 1 was held in 188 adult epilepsy patients with focal seizures across 14 sites in Australia and New Zealand. When compared to placebo,
According to Lilly, the primary endpoint of the phase 3 SPARTAN trial was comparison of the percentage of patients in the lasmiditan 200mg and placebo groups who were
Although, the FDA is not obliged to go by the recommendation of the committee, more often or not it takes its advice into consideration. The drug, which is
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.